Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Schedule Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01927965
What this trial is testing

Study of Minnelide™ in Patients With Advanced GI Tumors

Who this might be right for
Advanced Gastrointestinal Tumors
Minneamrita Therapeutics LLC 45
Testing effectiveness (Phase 2)Study completedNCT02561195
What this trial is testing

Investigate Two 3-dose Schedules Of A Clostridium Difficile Vaccine In Healthy Adults Aged 65 to 85 Years

Who this might be right for
Clostridium Difficile Associated Disease
Pfizer 300
Testing effectiveness (Phase 2)UnknownNCT00017992
What this trial is testing

Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV

Who this might be right for
HIV Infections
Triangle Pharmaceuticals 100
Large-scale testing (Phase 3)Study completedNCT00849160
What this trial is testing

Study of Protease Inhibitor Regimen Switch in HIV-1 Infected Patients With Undetectable Viral Load to Prove the Non-inferiority of Once Daily Dose Regimen Versus the Current Twice Daily Regimen to Maintain the Viral Load Under the Limit of Detection.

Who this might be right for
HIV-1 InfectionHIV Infections
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida 100
Large-scale testing (Phase 3)Study completedNCT00158730
What this trial is testing

Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial Treatment

Who this might be right for
Invasive AspergillosisOther Fungal Infections
Gilead Sciences 800
Early research (Phase 1)Study completedNCT07091929
What this trial is testing

A Research Study to Evaluate the Safety and Preliminary Efficacy of SGC001 in Patients With Myocardial Infarction

Who this might be right for
Anterior Myocardial Infarction
Beijing Sungen Biomedical Technology Co., Ltd 38
Testing effectiveness (Phase 2)Study completedNCT02500550
What this trial is testing

Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Kiadis Pharma 15
Testing effectiveness (Phase 2)Study completedNCT00697853
What this trial is testing

Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults

Who this might be right for
Hepatitis B
GlaxoSmithKline 200
Testing effectiveness (Phase 2)Study completedNCT06663436
What this trial is testing

A Study on the Immune Response and Safety of a Multicomponent Shigella Vaccine in Preventing Shigellosis in Infants

Who this might be right for
Diarrhoea
GlaxoSmithKline 200
Post-approval studies (Phase 4)Study completedNCT03723837
What this trial is testing

Persistence of IPV Immunity

Who this might be right for
Poliomyelitis
Tribhuvan University Teaching Hospital, Institute Of Medicine. 502
Early research (Phase 1)Study completedNCT01353781
What this trial is testing

Open Label Phase 1 Study in Japan for Patient With Advanced Solid Malignancies

Who this might be right for
Advanced Solid MalignancyAdvanced Solid Tumor
AstraZeneca 39
Testing effectiveness (Phase 2)Ended earlyNCT05161481
What this trial is testing

Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

Who this might be right for
Hypertension, Portal
Boehringer Ingelheim 80
Testing effectiveness (Phase 2)Study completedNCT00116376
What this trial is testing

Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
Novartis Pharmaceuticals 64
Post-approval studies (Phase 4)UnknownNCT01481714
What this trial is testing

Efficacy and Safety of Split-dose Citrafleet Administered From 2 to 6 Hours Before Morning Colonoscopies

Who this might be right for
Bowel CleansingColonoscopy
Infante, Javier Molina, M.D. 300
Early research (Phase 1)Study completedNCT00005616
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center 12
Early research (Phase 1)Study completedNCT01226316
What this trial is testing

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

Who this might be right for
Advanced Solid MalignancySafety and TolerabilityPharmacokinetics+11 more
AstraZeneca 285
Post-approval studies (Phase 4)Study completedNCT00233532
What this trial is testing

Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)

Who this might be right for
Hypertension
Abbott 2,000
Early research (Phase 1)Ended earlyNCT00607399
What this trial is testing

Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors

Who this might be right for
Advanced Cancer
SGX Pharmaceuticals, Inc. 46
Testing effectiveness (Phase 2)Study completedNCT00109707
What this trial is testing

Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)Hypereosinophilic Syndrome+1 more
Novartis Pharmaceuticals 507
Large-scale testing (Phase 3)Ended earlyNCT00434096
What this trial is testing

Japanese Study of Rimonabant in Obese Patients With Dyslipidemia (VENUS)

Who this might be right for
Obesity
Sanofi 915
Next Page